An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies
Clinical trial NCT03842969 · COMPLETED
Trial details
- NCT number
- NCT03842969
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2022-03-25
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.